Brief: Eagle Pharmaceuticals Delivers Notice Of Termination Of License Deal To AOP
09/06/2023 21:14
June 9 (Reuters) - Eagle Pharmaceuticals Inc EGRX.O :
* EAGLE PHARMACEUTICALS - ON JUNE 6, DELIVERED NOTICE OF
TERMINATION TO AOP ORPHAN PHARMACEUTICALS GMBH RELATED TO
LICENSE DEAL, DATED AUGUST 6, 2021
* EAGLE PHARMACEUTICALS INC - NOTICE PROVIDES THAT AOP
LICENSE BE
TERMINATED EFFECTIVE IMMEDIATELY
Further company coverage: EGRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eagle Pharmaceuticals
See all newsDoes a common heart attack pill help everyone? Studies disagree
Brief: Eagle Pharmaceuticals Says Continuing To Evaluate Its Internal Control Over Financial Reporting
Brief: Nantahala Capital Management, Llc Reports 15.1% Passive Stake In Eagle Pharmaceuticals Inc As Of June 30- SEC Filing
Brief: Eagle Pharmaceuticals Says On May 28, Co Requested Hearing Before Hearings Panel Of Nasdaq, Following Delisting Notice From Nasdaq - SEC Filing
Brief: Eagle Pharmaceuticals Announces Receipt Of Delisting Notification From Nasdaq